LYSOCLEAR

Lysoclear, Inc. is a pre-clinical Ichor Therapeutics portfolio company that develops enzyme therapies for eye disease. The company is currently developing leads to treat atrophic “dry” age-related macular degeneration and Stargardt’s macular degeneration.

#SimilarOrganizations #Financial #Website #More

LYSOCLEAR

Industry:

Biotechnology Life Science

Founded:

2016-01-01

Address:

Lafayette, Louisiana, United States

Country:

United States

Website Url:

http://www.lysoclear.com

Total Employee:

1+

Status:

Active

Contact:

Total Funding:

3 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS Google Google Cloud AWS Global Accelerator WP Engine

Similar Organizations

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

renovacor-logo

Renovacor

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

Investors List

grapeseed-bio_image

Grapeseed.Bio

Grapeseed.Bio investment in Venture Round - Lysoclear

kizoo_image

KIZOO Technology Capital

KIZOO Technology Capital investment in Seed Round - Lysoclear

Official Site Inspections

http://www.lysoclear.com

Host Informations
Whois Informations

Loading ...

More informations about "Lysoclear" on Search Engine